Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Dev Patel, Dany Alkurdi, Curtis Tam, Rachel Goodman et autres
us (code pays fourni par la source)
J. B. Justice, Hannah Burnette, Rebecca Irlmeier, Fei Ye et autres
Background/Objectives: Immune checkpoint inhibitors (ICIs) have revolutionized outcomes for patients with melanoma. As such, it is important to understand factors that may influence response as well as toxicity to these therapies. Impaired glucose control is often a sign of pathologic inflammation and …
us (code pays fourni par la source)
John R. Power, Charles Dolladille, Benay Özbay, Adrien Procureur et autres
BACKGROUND AND AIMS: Immune checkpoint inhibitors (ICI) are associated with life-threatening myocarditis but milder presentations are increasingly recognized. The same autoimmune process that causes ICI myocarditis can manifest concurrent generalized myositis, myasthenia-like syndrome, and respiratory muscle failure. Prognostic factors for this 'cardiomyotoxicity' …
us, fr, de, il, jp, at, au, gb, es, ch, tw (code pays fourni par la source)
Florentia Dimitriou, Marlana Orloff, Erica C. Koch Hein, Phil F. Cheng et autres
BACKGROUND: Metastatic uveal melanoma (mUM) is rare. Immune checkpoint inhibitors (ICIs) have shown modest efficacy in mUM. Tebentafusp prolonged overall survival (OS) in a phase 3 study. We aimed to investigate the efficacy and safety of the sequence of tebentafusp and ICIs. …
ch, us, ca, it, au, fr, nl, de (code pays fourni par la source)
Rachel Woodford, Janet McKeown, Lotte Hoeijmakers, Johanna Mangana et autres
au, nl, ch, us, fr, es, pl, be, it (code pays fourni par la source)
Rachel Goodman, Seungyeon Jung, Kylie Fletcher, Hannah Burnette et autres
Identifying patients likely to benefit from immune checkpoint inhibitor (ICI) treatment remains a crucial goal for melanoma. The objective of this study is to assess the association between primary tumor features and immunotherapy response and survival in advanced melanoma patients. In this …
us (code pays fourni par la source)
Isik Turker, Douglas B. Johnson
INTRODUCTION: Myocarditis associated with immune checkpoint inhibitors presents with an often-severe clinical phenotype with arrhythmias and concurrent myositis. This condition tends to occur early after treatment onset and is associated with a high fatality rate. Diagnosis may be challenging, and treatment algorithms …
us (code pays fourni par la source)
Vickie R. Shannon, Ronald Anderson, Ada G. Blidner, Jennifer Choi et autres
us, Afrique du Sud, ar, gb (code pays fourni par la source)
María E. Suarez‐Almazor, Xerxes Pundole, Noha Abdel‐Wahab, Douglas B. Johnson et autres
us, gb, Afrique du Sud, ar (code pays fourni par la source)
Marc S. Ernstoff, Igor Puzanov, Caroline Robert, Adi Diab et autres
Daniel Wang, Joe‐Elie Salem, Justine V. Cohen, Sunandana Chandra et autres
Importance: Immune checkpoint inhibitors (ICIs) are now a mainstay of cancer treatment. Although rare, fulminant and fatal toxic effects may complicate these otherwise transformative therapies; characterizing these events requires integration of global data. Objective: To determine the spectrum, timing, and clinical features …
us, fr, de, au (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic